Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Health and economic outcomes of vancomycin-resistant enterococci
Yehuda Carmeli
*
, George Eliopoulos
, Essy Mozaffari
, Matthew Samore
*
Corresponding author for this work
Harvard University
Tel Aviv Sourasky Medical Center
Pfizer
University of Utah
Research output
:
Contribution to journal
›
Article
›
peer-review
218
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Health and economic outcomes of vancomycin-resistant enterococci'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Relative Risk
100%
Economic Outcomes
100%
Health Outcomes
100%
Vancomycin-resistant Enterococcus Faecium (VREfm)
100%
Length of Stay
42%
Intensive Care Unit Admission
28%
Comorbidity
14%
Confounding
14%
Control Subjects
14%
Risk Measures
14%
Sodium
14%
Patient Characteristics
14%
Increased Mortality
14%
Economic Impact
14%
Linear Regression
14%
Multivariable Model
14%
Length of Hospital Stay
14%
Patient Outcomes
14%
Primary Diagnosis
14%
Patients Included
14%
Long-term Care
14%
Case Fatality Rate
14%
Metronidazole
14%
Cephalosporins
14%
Conditional Logistic Regression
14%
Clostridioides Difficile
14%
Past Infection
14%
Health Impact
14%
Accelerated Failure Time Model
14%
Propensity Score
14%
Hospital Population
14%
Hospital Costs
14%
Intensive Care Unit Discharge
14%
Mortality Costs
14%
Severe Adverse Events
14%
Matched Cohort Study
14%
Morbimortality
14%
Methicillin
14%
Multidrug-resistant Staphylococcus Aureus
14%
Control Risk
14%
2-length
14%
Calendar Date
14%
Hospital Location
14%
Medicine and Dentistry
Vancomycin Resistant Enterococcus
100%
Health Care Cost
40%
Intensive Care Unit
40%
Infection
20%
Logistic Regression Analysis
20%
Linear Regression Analysis
20%
Cohort Analysis
20%
Patient Characteristics
20%
Adverse Outcome
20%
Morbidity
20%
Staphylococcus Aureus
20%
Meticillin
20%
Case Fatality Rate
20%
Long-Term Care
20%
Peptoclostridium difficile
20%
Cephalosporin Derivative
20%
Metronidazole
20%
Surgical Mortality
20%
Hospital Cost
20%
Comorbidity
20%
Nursing and Health Professions
Vancomycin-Resistant Enterococcus
100%
Length of Stay
60%
Logistic Regression Analysis
20%
Long Term Care
20%
Linear Regression Analysis
20%
Morbidity
20%
Intensive Care Unit
20%
Infection
20%
Adverse Outcome
20%
Cohort Analysis
20%
Meticillin
20%
Case Fatality Rate
20%
Propensity Score
20%
Surgical Intensive Care Unit
20%
Hospital Cost
20%
Metronidazole
20%
Cephalosporin Derivative
20%
Comorbidity
20%
Immunology and Microbiology
Vancomycin-Resistant Enterococcus
100%
Staphylococcus Aureus
20%
Infectious Disease
20%
Morbidity
20%
Case Fatality Rate
20%
Peptoclostridium difficile
20%
Surgical Mortality
20%
Comorbidity
20%
Infection
20%